Synthetic porcine cutaneous growth protein (rEGF) is demonstrating increased interest as a promising approach in the area of wound therapy. This biological agent, manufactured through genetic technology, provides a https://recombinant-porcine-egf643778.p2blogs.com/41250211/engineered-pig-epidermal-growth-protein-a-significant-method-for-wound-regeneration